DANEEN LOCKE: Open Payments
NPI 1740314970 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,195 in 153 payments from 22 companies in 2025. Trend: 2023 $1,442 · 2024 $3,566 · 2025 $3,195
Food & beverage: $3,195
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $647 |
| Janssen Biotech, Inc. | 13 | $359 |
| Incyte Corporation | 15 | $341 |
| GENZYME CORPORATION | 8 | $243 |
| Regeneron Healthcare Solutions, Inc. | 8 | $217 |
| Novartis Pharmaceuticals Corporation | 18 | $193 |
| Galderma Laboratories, L.P. | 16 | $174 |
| Amgen Inc. | 12 | $165 |
| PFIZER INC. | 6 | $126 |
| UCB, Inc. | 4 | $121 |
Products named: DUPIXENT, TREMFYA, OPZELURA, SKYRIZI, RINVOQ, NEMLUVIO, OTEZLA, COSENTYX.
Industry payments across MI — which companies pay providers there.
